Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-30 07:02 am Purchase |
2023-12-29 | 13G | Doximity, Inc. DOCS |
BAILLIE GIFFORD & CO | 6,299,503 5.330% |
6,299,503 (New Position) |
Filing History |
| 2024-01-30 06:59 am Sale |
2023-12-29 | 13G | Denali Therapeutics Inc. DNLI |
BAILLIE GIFFORD & CO | 14,260,724 10.320% |
-858,750 (-5.68%) |
Filing History |
| 2024-01-30 06:49 am Purchase |
2023-12-29 | 13G | Coursera, Inc. COUR |
BAILLIE GIFFORD & CO | 24,156,815 15.840% |
6,050,119 (+33.41%) |
Filing History |
| 2024-01-30 06:45 am Purchase |
2023-12-29 | 13G | Coupang, Inc. CPNG |
BAILLIE GIFFORD & CO | 145,524,128 9.020% |
30,348,028 (+26.35%) |
Filing History |
| 2024-01-30 06:41 am Sale |
2023-12-29 | 13G | Copa Holdings, S.A. CPA |
BAILLIE GIFFORD & CO | 3,803,340 11.970% |
-819,984 (-17.74%) |
Filing History |
| 2024-01-30 06:37 am Sale |
2023-12-29 | 13G | Cloudflare, Inc. NET |
BAILLIE GIFFORD & CO | 30,938,677 10.460% |
-990,305 (-3.10%) |
Filing History |
| 2024-01-30 06:31 am Purchase |
2023-12-29 | 13G | Chewy, Inc. CHWY |
BAILLIE GIFFORD & CO | 18,482,764 15.370% |
1,401,770 (+8.21%) |
Filing History |
| 2024-01-30 06:27 am Sale |
2023-12-29 | 13G | Certara, Inc. CERT |
BAILLIE GIFFORD & CO | 8,921,463 5.580% |
-1,302,346 (-12.74%) |
Filing History |
| 2024-01-30 06:22 am Purchase |
2023-12-29 | 13G | Atlassian Corporation TEAM |
BAILLIE GIFFORD & CO | 8,807,619 5.680% |
1,331,373 (+17.81%) |
Filing History |
| 2024-01-29 12:18 pm Sale |
2023-12-29 | 13G | Alnylam Pharmaceuticals, Inc. ALNY |
BAILLIE GIFFORD & CO | 6,967,097 5.550% |
-2,440,774 (-25.94%) |
Filing History |
| 2024-01-29 12:02 pm Unchanged |
2023-12-29 | 13G | Akili, Inc. AKLI |
BAILLIE GIFFORD & CO | 4,665,795 5.960% |
0 (Unchanged) |
Filing History |
| 2024-01-29 11:55 am Sale |
2023-12-29 | 13G | Affirm Holdings, Inc. AFRM |
BAILLIE GIFFORD & CO | 20,467,614 8.450% |
-2,236,095 (-9.85%) |
Filing History |
| 2024-01-29 11:52 am Sale |
2023-12-29 | 13G | Adaptimmune Therapeutics plc ADAP |
BAILLIE GIFFORD & CO | 95,472,840 7.010% |
-7,546,794 (-7.33%) |
Filing History |
| 2024-01-29 11:47 am Purchase |
2023-12-29 | 13G | AbCellera Biologics Inc. ABCL |
BAILLIE GIFFORD & CO | 24,044,796 8.290% |
4,348,061 (+22.08%) |
Filing History |
| 2024-01-29 11:43 am Sale |
2023-12-29 | 13G | 10x Genomics, Inc. TXG |
BAILLIE GIFFORD & CO | 7,919,976 7.600% |
-682,259 (-7.93%) |
Filing History |
| 2024-01-29 10:53 am Purchase |
2023-12-29 | 13G | Nanobiotix S.A. NBTX |
BAILLIE GIFFORD & CO | 2,869,030 6.210% |
1,355,823 (+89.60%) |
Filing History |
| 2024-01-29 10:49 am Purchase |
2023-12-29 | 13G | Moderna, Inc. MRNA |
BAILLIE GIFFORD & CO | 45,654,527 11.970% |
867,781 (+1.94%) |
Filing History |
| 2024-01-29 10:44 am Purchase |
2023-12-29 | 13G | Mobileye Global Inc. MBLY |
BAILLIE GIFFORD & CO | 8,424,283 8.900% |
2,241,922 (+36.26%) |
Filing History |
| 2024-01-29 10:40 am Sale |
2023-12-29 | 13G | MercadoLibre, Inc. MELI |
BAILLIE GIFFORD & CO | 5,383,227 10.650% |
-742,073 (-12.11%) |
Filing History |
| 2024-01-29 10:32 am Sale |
2023-12-29 | 13G | Lemonade, Inc. LMND |
BAILLIE GIFFORD & CO | 4,549,693 6.510% |
-341,511 (-6.98%) |
Filing History |